張嘉峰 科主任

張嘉峰醫師

醫師代碼 :15068
我要掛號

專 長

  • 一般泌尿學
  • 尿路結石治療
  • 攝護腺肥大
  • 排尿障礙
  • 一般泌尿科手術
  • 生殖泌尿道感染
  • 男性不孕症

現 職

  • 佛教慈濟醫療財團法人花蓮慈濟醫院 泌尿部 內視鏡泌尿科主任
  • 慈濟大學  部定講師
  • 台灣泌尿科醫學會 -- 功能性泌尿學委員會
  • 台灣泌尿科醫學會 -- 資訊及線上教育委員會委員
  • 台灣泌尿科醫學會 -- 專科醫師甄審委員會委員

學 歷

  • 慈濟大學醫學系

經 歷

  • 美國匹茲堡大學醫學院(University of Pittsburgh )進修排尿障礙及膀胱生理學
  • 2017年歐洲泌尿科醫學會研究醫師交換訓練計畫(fellowship exchange program)
  • 佛教慈濟醫療財團法人花蓮慈濟醫院 泌尿部 內視鏡泌尿科代主任
  • 佛教慈濟醫療財團法人花蓮慈濟醫院 泌尿部 主治醫師
  • 佛教慈濟醫療財團法人花蓮慈濟醫院 泌尿部 臨床研究醫師
  • 佛教慈濟醫療財團法人花蓮慈濟醫院 泌尿部 總醫師
  • 佛教慈濟醫療財團法人花蓮慈濟醫院 泌尿部 住院醫師

獲獎及其他榮譽

  • 104年泌尿科專科醫師考試筆試全國第一名
  • 105年台灣泌尿科醫學會雜誌-會員基礎組論文獎
  • 105年台灣泌尿科醫學會論文獎-理事長論文獎
  • 106年慈濟醫學年會個人年輕最佳研究成果獎 第二名
  • 107年慈濟醫學年會個人年輕最佳研究成果獎 第一名

著 作 / 論文 相關

【2013】
  • Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms. Jhang JF, Jiang YH, Kuo HC. Int J Clin Pract. 2013 Dec;67(12):1327-33 (SCI)
  • Transurethral Incision of the bladder neck improves voiding efficiency in female patients with detrusor underactivity. Jhang JF, Jiang YH, Kuo HC. Int Urogynecol J.  2014 May;25(5):671-6.  (SCI)
  • Down Regulation of Vascular Endothelial Growth Factor Is Associated With Decreased Inflammation After Intravesical OnabotulinumtoxinA Injections Combined With Hydrodistention for Patients With Interstitial Cystitis-Clinical Results and Immunohistochemistry Analysis. Peng CH, Jhang JF, Shie JH, Kuo HC. Urology. 2013 Dec ;82(6):1452.e1-6. (SCI)
  • Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia. Jia-Fong Jhang, Chun-Hou Liao, Hann-Chorng Kuo. Int J Clin Pract. 2014 Jun;68(6):743-8. (SCI)
  • Characteristics and electrocauterization of Hunner's lesions associated with bladder pain syndrome   Urological Science, Volume 24, Issue 2, June 2013, Pages 51-55. Jia-Fong Jhang, Yung-Hsiang Hsu, Hann-Chorng Kuo
【2014】
  • Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis. Jia-Fong Jhang, Hann-Chorng Kuo. Int J Urol 2014 Apr;21 Suppl 1:49-55 (SCI)
  • Elevated Serum Immunoglobulin E May Be Associated to the Development of Ketamine Cystitis. Jhang JF, Hsu YH, Jiang YH, Kuo HC. J Urol. 2014 Oct;192(4):1249-56 (SCI)
【2015】
  • Possible Pathophysiology of Ketamine-Related Cystitis and associated Treatment Srategies. Jhang JF, Hsu YH, Kuo HC. Int J Urol. 2015 Sep;22(9):816-25. (SCI)
  • Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection. Jhang JF, Kuo HC. Toxins (Basel). 2015 Jun 18;7(6):2232-50 (SCI)
  • Role of serum immunoglobulin E in patients with interstitial cystitis/bladder pain syndrome. Jhang JF, Kuo HC. Urological Science 26 (2015) 202-205
  • Long-term follow up and predictive factors for successful outcome of transurethral incision of the bladder neck in women with detrusor underactivity. Jhang JF, Jiang YH, Lee CL, Kuo HC. J Formos Med Assoc. 2015 Sep 12. pii: S0929-6646(15)00307-1 (SCI)
【2016】
  • The Role of Immunoglobulin E in the Pathogenesis of Ketamine Related Cystitis and Ulcerative Interstitial Cystitis – an Immunohistochemical Study. Jhang JF, Hsu YH, Jiang YH, Kuo HC. Pain physician 2016 19(4):E581-7.
  • Patient characteristics for different therapeutic strategies in the management ketamine cystitis. Jhang JF, Birder LA, Chancellor MB, Kuo HC. Neurourol Urodyn. 2016 Mar 21. (SCI)
  • Revisiting the Role of Potassium Sensitivity Testing and Cystoscopic Hydrodistention for the Diagnosis of Interstitial Cystitis. Jiang YH, Jhang JF, Kuo HC. PLoS One. 2016 Mar 21;11(3):e0151692. (SCI)
  • Urothelial functional protein and sensory receptors in patients with interstitial cystitis/bladder pain syndrome with and without Hunner’s lesion. Jhang JF, Hsu YH, Kuo HC. Urology 2016 Dec;98:44-49 (SCI)
【2017】
  • Bladder dysfunction in 2016: New insights into interstitial cystitis and chronic pelvic pain syndromes. Jhang JF, Kuo HC. Nat Rev Urol. 2017 Feb;14(2):69-70. (SCI)
  • Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease. Jhang JF, Kuo HC. Int Neurourol J. 2016 Nov;20(Suppl 2):S95-104. Epub 2016 Nov 22 (SCI)
  • Clinical Outcome of Augmentation Enterocystoplasty for Patients with Ketamine-induced Cystitis. Lee YK, Jhang JF, Kuo HC. Pain Physician. 2017 Mar;20(3):E431-E436.(SCI)
  • Recent advances in recurrent urinary tract infection from pathogenesis and biomarkers to prevention. Jhang JF, Kuo HC.Ci Ji Yi Xue Za Zhi. 2017 Jul-Sep;29(3):131-137.Review (SCI)
  • Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity. Jiang YH, Jhang JF, Chen SF, Kuo HC.Low Urin Tract Symptoms. 2017 Oct 11. doi: 10.1111/luts.12195. [Epub ahead of print] (SCI)
  • Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study. Jhang JF, Wu SY, Lin TY, Kuo HC.Low Urin Tract Symptoms. 2017 Dec 19. doi: 10.1111/luts.12212. [Epub ahead of print] (SCI)
  • Current pharmacological and surgical treatment of underactive bladder. Jiang YH, Lee CL, Jhang JF, Kuo HC.Ci Ji Yi Xue Za Zhi. 2017 Oct-Dec;29(4):187-191. doi: 10.4103/tcmj.tcmj_122_17. Review. (SCI)
【2018】
  • Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial. Jiang YH, Jhang JF, Lee CL, Kuo HC.Neurourol Urodyn. 2018 Apr;37(4):1467-1473. doi: 10.1002/nau.23475. (SCI)
  • Histopathological characteristics of ketamine-associated uropathy and their clinical association. Jhang JF, Hsu YH, Jiang YH, Lee CL, Kuo HC. Neurourol Urodyn. 2018 Feb 14. doi: 10.1002/nau.23514. [Epub ahead of print] (SCI)
  • Vascular fibrinoid necrosis in the urinary bladder of ketamine abusers: A new finding that may provide a clue to the pathogenesis of ketamine-induced vesicopathy. Chen YC, Jhang JF, Hsu YH, Kuo HC. Low Urin Tract Symptoms. 2018 Mar 11. doi: 10.1111/luts.12221. [Epub ahead of prin] (SCI)
  • Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome. Jhang JF, Hsu YH, Peng CW, Jiang YH, Ho HC, Kuo HC. J Urol. 2018 Apr 11. pii: S0022-5347(18)42926-6. doi: 10.1016/j.juro.2018.03.133. [Epub ahead of print] (SCI)
  • Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity. Jiang YH, Chen SF, Jhang JF, Kuo HC. Neurourol Urodyn. 2018 May 24. doi: 10.1002/nau.23714. [Epub ahead of print] (SCI)
  • Electron microscopic characteristics of interstitial cystitis/bladder pain syndrome and their association with clinical condition. Jhang JF, Ho HC, Jiang YH, Lee CL, Hsu YH, Kuo HC. PLoS One. 2018 Jun 7;13(6):e0198816. doi: 10.1371/journal.pone.0198816. eCollection 2018.(SCI)
  • Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction. Jhang JF, Kuo HC. Toxins (Basel). 2018 Jun 26;10(7). pii: E260. doi: 10.3390/toxins10070260. Review. (SCI)
  • Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial. Jiang YH, Jhang JF, Lee CL, Kuo HC.Neurourol Urodyn. 2018 Apr;37(4):1467-1473. doi: 10.1002/nau.23475. (SCI)
  • Histopathological characteristics of ketamine-associated uropathy and their clinical association. Jhang JF, Hsu YH, Jiang YH, Lee CL, Kuo HC. Neurourol Urodyn. 2018 Feb 14. doi: 10.1002/nau.23514. [Epub ahead of print] (SCI)
  • Vascular fibrinoid necrosis in the urinary bladder of ketamine abusers: A new finding that may provide a clue to the pathogenesis of ketamine-induced vesicopathy. Chen YC, Jhang JF, Hsu YH, Kuo HC. Low Urin Tract Symptoms. 2018 Mar 11. doi: 10.1111/luts.12221. [Epub ahead of prin] (SCI)
  • Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome. Jhang JF, Hsu YH, Peng CW, Jiang YH, Ho HC, Kuo HC. J Urol. 2018 Apr 11. pii: S0022-5347(18)42926-6. doi: 10.1016/j.juro.2018.03.133. [Epub ahead of print] (SCI)
  • Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity. Jiang YH, Chen SF, Jhang JF, Kuo HC. Neurourol Urodyn. 2018 May 24. doi: 10.1002/nau.23714. [Epub ahead of print] (SCI)
  • Electron microscopic characteristics of interstitial cystitis/bladder pain syndrome and their association with clinical condition. Jhang JF, Ho HC, Jiang YH, Lee CL, Hsu YH, Kuo HC. PLoS One. 2018 Jun 7;13(6):e0198816. doi: 10.1371/journal.pone.0198816. eCollection 2018.(SCI)
  • Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction. Jhang JF, Kuo HC. Toxins (Basel). 2018 Jun 26;10(7). pii: E260. doi: 10.3390/toxins10070260. Review. (SCI)
  • Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome.Jhang JF, Hsu YH, Peng CW, Jiang YH, Ho HC, Kuo HC.J Urol. 2018 Sep;200(3):590-596. doi: 10.1016/j.juro.2018.03.133. Epub 2018 Apr 11.PMID: 29653163
  • Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity.Jiang YH, Chen SF, Jhang JF, Kuo HC.Neurourol Urodyn. 2018 Nov;37(8):2651-2657. doi: 10.1002/nau.23714. Epub 2018 May 24.PMID: 29797345

【2019】

【2020】

【2021】

【2022】

【2023】

【2024】

 

 

 

 

Copyright © 2017 花蓮慈濟醫學中心. 版權所有. 地址：花蓮市中央路三段707號　連絡電話：03-8561825